Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.

Sweden's Ambassador to Indonesia, Timor-Leste, Papua New Guinea, and ASEAN, Daniel Blockert, mentioned that Sweden and ...

GLP-1 receptor agonists may aid smoking cessation by curbing cravings and mitigating weight gain, which often are impediments in quitting, according to a presentation at the American Psychiatric ...

A groundbreaking new drug called zilebesiran has shown that just one injection every six months, when added to standard pills, can significantly lower blood pressure by 4 to 12 points depending on the ...

The guideline provides pragmatic, evidence-based, easy-to-implement recommendations and streamlined algorithms.

The Obesity Drugs Market is experiencing unprecedented growth, driven by increasing global obesity rates, sedentary ...